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Abstract
Background:  Target genes of a transcription factor (TF) Pou5f1  (Oct3/4  or  Oct4), which is
essential for pluripotency maintenance and self-renewal of embryonic stem (ES) cells, have
previously been identified based on their response to Pou5f1 manipulation and occurrence of
Chromatin-immunoprecipitation (ChIP)-binding sites in promoters. However, many responding
genes with binding sites may not be direct targets because response may be mediated by other
genes and ChIP-binding site may not be functional in terms of transcription regulation.
Results: To reduce the number of false positives, we propose to separate responding genes into
groups according to direction, magnitude, and time of response, and to apply the false discovery
rate (FDR) criterion to each group individually. Using this novel algorithm with stringent statistical
criteria (FDR < 0.2) to a compendium of published and new microarray data (3, 6, 12, and 24 hr
after Pou5f1 suppression) and published ChIP data, we identified 420 tentative target genes (TTGs)
for Pou5f1. The majority of TTGs (372) were down-regulated after Pou5f1 suppression, indicating
that the Pou5f1  functions as an activator of gene expression when it binds to promoters.
Interestingly, many activated genes are potent suppressors of transcription, which include
polycomb genes, zinc finger TFs, chromatin remodeling factors, and suppressors of signaling. Similar
analysis showed that Sox2 and Nanog also function mostly as transcription activators in cooperation
with Pou5f1.
Conclusion: We have identified the most reliable sets of direct target genes for key pluripotency
genes – Pou5f1, Sox2, and Nanog, and found that they predominantly function as activators of
downstream gene expression. Thus, most genes related to cell differentiation are suppressed
indirectly.
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Background
Identification of direct targets of transcription factors
(TFs) is a necessary step to reconstruct gene regulatory net-
works in living cells. Although traditional single-gene
experiments (e.g., assaying promoter activity using a pro-
moter-reporter gene construct) remain most reliable in
testing direct targets, there is also a need for high-through-
put approaches that would allow one to detect the major-
ity of most important target genes. Two experimental
methods contribute most to such a high-throughput
search of target genes: gene expression profiling of TF-
manipulated cells and genome-wide chromatin immuno-
precipitation (ChIP) assay. However, expression profiling
may yield many genes that respond indirectly, whereas
ChIP may yield many non-functional binding sites, i.e.,
binding sites that were detected by ChIP, but were not
functional for transcriptional regulation. Therefore, the
state of the art is to take the intersection between these
two sets of genes (i.e. select genes that responded to the
manipulation of a TF and have binding sites) and con-
sider it as a set of tentative target genes (TTGs) [1,2]. How-
ever, the intersection of these sets of genes may still
contain numerous false positives – genes that respond
indirectly and have non-functional ChIP-binding sites.
Another problem is that there is no method to statistically
quantify the proportion of false positives in the set of
TTGs.
To address these issues, we developed a new method to
identify TTGs, which reduces the proportion of false posi-
tives by applying the False Discovery Rate (FDR) criterion
to individual groups of genes that differ in the direction,
magnitude, and time of response to the manipulation of
a TF. The computational strategy included optimization of
Scores of Potential Function (SPF) of binding sites that
separated best the training and control sets of genes, and
estimation of the FDR from the frequency distribution of
SPF among control genes (Fig. 1).
A flow chart showing algorithm used to identify tentative target genes for a transcription factor Figure 1
A flow chart showing algorithm used to identify tentative target genes for a transcription factor. The algorithm 
includes the optimization of Scores of Potential Function (SPF) based on the comparison of training and control sets of genes, 
and the estimation of False Discovery Rates (FDR) within individual groups of responding genes.
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This method is applied here to the mouse Pou5f1 (Oct3/4,
Oct4) gene which is the major TF that controls self-
renewal and pluripotency in ES cells [3,4]. Lists of poten-
tial target genes of POU5F1 were recently generated using
chromatin immunoprecipitation (ChIP) and gene expres-
sion profiling of cells with suppressed Pou5f1 transcrip-
tion [1,5]. Most studies used shRNA for Pou5f1
suppression [1,5], but these methods can generate off-tar-
get effects, and gene repression is often weak. In these
studies, expression profiling was carried out with 1 day
intervals which limited the temporal resolution in detect-
ing gene response. Matoba et al. [2] increased the reliabil-
ity of prediction of Pou5f1 primary targets by using a tet-
inducible system to suppress Pou5f1. This method elimi-
nated false-positives related to potential off-target effects
of shRNA used to suppress Pou5f1 in earlier studies. How-
ever, gene expression was still measured in 1 day intervals,
and microarrays did not include all the mouse genes. In
this paper we present a new microarray experiment with
the same tet-inducible system but with multiple time
points within 24 hr to capture early responses to Pou5f1
suppression. These data were analyzed together with pub-
lished genome-wide ChIP data [1]. We found that most
TTGs of Pou5f1 in ES cells were activated by Pou5f1 and
only a limited number of genes were suppressed, which
implies that the main function of Pou5f1 binding to pro-
moters of target genes is activation of gene expression
rather than suppression. The same method was then
applied to find target genes of Sox2  and  Nanog  based
mostly on previously published data. A list of data sets
used in this study is shown in Additional file 1. Because
the interaction between POU5F1, SOX2, and NANOG is
supported by immunoprecipitation, functional analysis,
and co-localization of binding sites [6,1,7-10], we
explored the relationships between their target genes.
These results are discussed in relation to the mechanism
of pluripotency maintenance in ES cells.
Results and Discussion
1. Time course microarray data
We previously reported time course microarray data of
mouse ES cells, in which the level of Pou5f1 expression
was reduced in tetracycline (Tet)-controllable manner [2].
Global gene expression profiles were obtained from ES
samples at 24, 48, 72, 96, and 120 hr [2]. To obtain earlier
effects of Pou5f1  repression, here we used the same
ZHBTc4 ES cells [4] and measured the global gene expres-
sion profiles at 0, 3, 6, 12, and 24 hr after adding Tet.
Because the 24 hr time point was present in both experi-
ments, the microarray data at 24 hr was used to merge two
data sets (see Methods) (Additional file 2). In ZHBTc4 ES
cells, the level of Pou5f1 mRNA was reduced to one-thirds
within 3 hrs after adding Tet, whereas the same reduction
of POU5F1 protein level was observed in 6 hrs (Addi-
tional file 3). The cells show no morphological changes
associated with differentiation during the first 24 hrs after
adding Tet, but the cells begin to be flattened after 48 hrs
[4]. We found 6197 genes with a statistically significant
(FDR <= 0.05, fold change >= 1.5) response to Pou5f1 sup-
pression (Additional file 4). A subset of these genes with
> 2 fold change (N = 2600) overlapped reasonably (N =
1319, 50.7%) with gene lists identified earlier using
Pou5f1 knockdown with shRNA [5,1] (Additional file 5A).
The majority (N = 1185, 96.7%) of 1225 genes common
between our study and the published study [1], changed
their expression in the same direction after Pou5f1 sup-
pression, which was significantly greater than expected
from random matches (chi-square = 685, p = 10-150)
(Additional file 5B). Discrepancies between data sets may
be explained by off-target effects of shRNA in earlier stud-
ies and by a larger coverage of genes in our microarrays.
Genes that were previously considered targets of POU5F1
[1], but had no response to Pou5f1 suppression in our
experiments (N = 487), were not artifacts of microarray
design, because the majority of these genes (N = 442) had
functional oligos in our microarray that showed statisti-
cally significant differential expression in earlier experi-
ments [2,11].
Although several methods to analyze time course microar-
ray data have been reported (e.g. clustering [12,13],
splines [14,15]), we decided to characterize the pattern of
gene expression in a simpler way by 2 major parameters:
the time of response when it exceeded 1.5-fold change
threshold, and the magnitude of response measured by
the maximum logratio of expression change (Fig. 2C,
Additional file 4) (see Materials and methods for details).
The scatterplot of magnitude of response versus time of
response for all genes with statistically significant change
of expression (FDR <= 0.05, fold change >= 1.5) shows the
global picture of gene expression change after manipula-
tion of the Pou5f1 (Fig. 2A). The initial response to
Pou5f1 suppression (< 24 hr) is characterized mostly by
down-regulation of many genes. It is followed by the wave
of gene up-regulation which becomes more intense after
36 hr. Genes with a strongest response had a tendency to
be activated or suppressed earlier than genes with a
weaker response. Earliest effects were suppression of TFs
Foxd3, Mybl2, Zic3, Klf2, and Nr0b1. Later but still within
12 hr we observed activation of TFs that are expressed in
trophectoderm (Eomes, Cdx2, Gata2, Irx3). Interestingly,
genes that are considered important for pluripotency in ES
cells (Sox2, Nanog, Klf4, Zfp42) responded with a consid-
erable delay (> 24 hr).
Gene expression profiling of ES cells after suppression of
Sox2 was carried out using the same protocol (Tet-induci-
ble transgene cell line 2TS22C; the same array platform)
as the experiment on Pou5f1 [16]. Thus, results on Sox2BMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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Gene expression responses to the suppression of Pou5f1 (A) or Sox2 (B) expression in ES cells Figure 2
Gene expression responses to the suppression of Pou5f1 (A) or Sox2 (B) expression in ES cells. Time and magni-
tude of responses were estimated from the time course microarray data using 1.5-fold expression changes as a threshold (C), 
and then used as coordinates in a scatter-plot. Tentative target genes were identified as shown in Fig 1.
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(Fig. 2B, Additional file 6) were fully compatible with that
for Pou5f1 experiment.
The proportion of genes that responded to the suppres-
sion of Pou5f1 and Sox2 increased in a similar manner
over time (Fig 3A), and the proportion of common genes
also increased with time (Fig. 3A, B). Principal Compo-
nent Analysis (PCA) showed that gene expression
response to Pou5f1  and  Sox2  suppression was similar
when projected on the first principal component (PC1)
(Fig 3C). PC1 seems to represent a transition of ES cells
from a pluripotent state to more differentiated states
because it is associated with a decreased expression of ES
cell specific genes (e.g., Nanog, Zfp42, Nr0b1, Tcl1, Dppa3,
Klf4, Jarid2), and increased expression of genes related to
differentiation (e.g., Esx1,  Gata2,  Gata6,  H19,  Hoxa1,
Msx2,  Plat, keratins). The second principal component
(PC2) represented minor fraction of genes that responded
differentially to the suppression of Sox2 and Pou5f1 (Fig.
3D).
Comparison of gene expression responses to suppression of Pou5f1 and Sox2: (A) number of genes with > 2 fold change in  gene expression after suppression of Pou5f1 and Sox2; (B) proportion of genes with consistent responses (i.e., common genes  whose expression changed in the same direction) and inconsistent responses (i.e., common genes whose expression changed  in the opposite direction) to Pou5f1 and Sox2 suppression among the combined list of genes that responded by > 2 fold to  either of these transcription factors; (C-D) Principal Component Analysis (PCA) of gene expression response to the suppres- sion of Pou5f1 and Sox2 based on combined data Figure 3
Comparison of gene expression responses to suppression of Pou5f1 and Sox2: (A) number of genes with > 2 fold 
change in gene expression after suppression of Pou5f1 and Sox2; (B) proportion of genes with consistent responses (i.e., com-
mon genes whose expression changed in the same direction) and inconsistent responses (i.e., common genes whose expres-
sion changed in the opposite direction) to Pou5f1 and Sox2 suppression among the combined list of genes that responded by > 
2 fold to either of these transcription factors; (C-D) Principal Component Analysis (PCA) of gene expression response to the 
suppression of Pou5f1 and Sox2 based on combined data.
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We did not have (Tet)-inducible Nanog ES cells, and thus
had to use the following three experimental results: (i)
time course (1 to 7 days) of shRNA-mediated knockdown
in ES cells [5], (ii) shRNA-mediated knockdown of Nanog
in ES cells [1], and (iii) stable over-expression of Nanog
performed in our laboratory (see Materials and methods).
The first data set was analyzed in a way similar to the
Pou5f1  data set; however because the experiment was
done without replications we combined data points (data
from day 3 and 4, and data from day 5, 6, and 7) as repli-
cations for statistical analysis (Additional file 7). Com-
bined data points showed similar gene expression profiles
based on Principal Component Analysis (PCA) (data not
shown). In the latter 2 data sets, we classified genes only
based on expression change (positive vs. negative, and > 2
fold change vs. < 2 fold change), and used these classes for
estimating the FDR (Additional files 8, 9). When we com-
bined these 3 data sets, the direction of gene response was
inverted for the experiment with Nanog over-expression to
make it compatible with other data, and genes showing
contradictory change were ignored. Because data on
Nanog  was obtained with different methods than on
Pou5f1 and Sox2, it should be interpreted with caution.
It is important to note that genes affected by the altera-
tions of Pou5f1, Sox2, and Nanog expression contain not
only primary (direct) targets of these TFs, but also second-
ary/tertiary targets as shown previously [2].
2. Data set of genome-wide Chromatin IP
We used genome-wide ChIP data of POU5F1 and
NANOG, published by Loh et al. [1]. All raw data were
remapped to the mouse genome sequences and analyzed
with the genome annotation using components of Cis-
View software, which includes information on the tran-
scription start sites (TSSs) [17]. As we pointed out in our
previous work [2], some known POU5F1 target genes
were missed in the POU5F1-target gene list assembled by
Loh et al. [1] partly due to the use of a stringent criteria
(i.e.,  ≥ 4 ditags). We therefore decided to use both
POU5F1 and NANOG ChIP data, when we searched for
POU5F1 target or NANOG target. Significant co-localiza-
tion of POU5F1, SOX2, and NANOG binding sites have
been clearly shown recently by ChIP-chip analysis [6]. In
mouse, the strength of NANOG binding (measured by the
number of ChIP-PET ditags) was positively associated
with the strength of POU5F1 binding to the same region
according to our re-analysis of ChIP data [1] (Additional
file 10). Our analysis of TF binding motifs in DNA regions
identified by ChIP [1] showed that ChIP-NANOG regions
(isolated with NANOG antibody) had a high abundance
of OCT-SOX composite binding motifs also known as
HMG/POU cassettes [9,10] (Additional file 7). This find-
ing also confirms co-localization of POU5F1, SOX2, and
NANOG binding sites. Moreover, ChIP-NANOG regions
that did not overlap with any ChIP-POU5F1 regions also
had an increased abundance of OCT-SOX composite
binding motifs (Additional file 7). This indicates that
NANOG binding can be used as additional evidence of
POU5F1 and SOX2 binding and vise versa. Therefore, it is
reasonable to use a combination of POU5F1 and NANOG
ChIP data for finding POU5F1 targets. For example, in the
original ChIP-PET analysis by Loh et al., only binding sites
with ≥ 4 ditags were considered reliable [1]. In contrast, in
our modified approach we could utilize POU5F1 binding
sites with only 2 or 3 ditags on condition that they had
additional NANOG ditags. This approach increases the
sensitivity of finding TF binding sites, but it may have a
down side of possibly being too inclusive.
We also used genome-wide ChIP data for SOX2 obtained
from human ES cells [18]. However, the human ChIP data
were analyzed separately and used only to provide addi-
tional gene list for SOX2 targets (see the section 5 below
for the details).
3. Evaluating the ChIP-binding sites with a score of 
potential function (SPF)
Presence of a ChIP-binding site of a TF in the promoter of
a gene is not yet an evidence of transcription regulation
because TF binding may be related to other cellular func-
tions or may be not functional at all. To evaluate the
potential functionality of POU5F1 binding sites in tran-
scription regulation we developed a score of potential
function (SPF), which was estimated using an ad hoc
equation:
SPF = [N1
a + (b·N2)a]·[max(D, 1000)/10000]c + d·X,
(1)
where N1 and N2 are the number of ChIP-PET ditags for
POU5F1 and NANOG (data from [1]), respectively, D is
the distance from binding region to TSS, X = 1 for CpG-
rich regions and 0 otherwise, and a, b, c, and d are adjust-
able parameters. As we discussed above, we used data on
NANOG binding so that it can provide additional evi-
dence of binding site function. Expression levels of Nanog
changed > 48 hr after Pou5f1 suppression; thus, the train-
ing sets did not contain genes which responded to Pou5f1
suppression indirectly via the effect of Nanog, and the use
of NANOG binding could not affect SPF in favor of indi-
rect effects. The SPF was optimized to best separate
between the training set of genes that responded to Pou5f1
suppression and control set of genes that were not affected
by  Pou5f1. We used 2 training sets of genes that were
down-regulated (N = 782) and up-regulated (N = 519),
respectively, by at least 2 fold and responded non-tran-
siently to Pou5f1  suppression within the time window
from 6 to 48 hr (Additional file 11). Genes that responded
earlier than 6 hr may have been affected by other factorsBMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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besides the gradually decreasing amount of POU5F1 pro-
tein, and genes that responded later than 48 hr are more
likely to be affected indirectly. The control set of genes (N
= 3048, Additional file 11) contained genes with
medium- or high-quality promoters [17] represented by a
responsive oligo in the microarray, which did not respond
to Pou5f1 and had no differential expression between ES
and TS cells [19]. Adjustable parameters were changed to
maximize the t-statistics for the difference in average SPF
values between the training and control set of genes (see
Methods for details). To avoid circular reference by esti-
mating SPF for genes in the training and control set with
parameters optimized for the same genes, we used the
bootstrap resampling method [20]. Scores for POU5F1
binding sites were positively affected by the number of
ChIP ditags and negatively affected by the distance from
TSS and by CpG richness of the sequence (Additional file
12). Down-regulated genes were more widely separated
from control genes by their average SPF than up-regulated
genes based on t statistics (Additional file 12). Character-
istics of binding sites with highest SPF for each gene are
given in Additional files 13 and 14.
4. Identification of Tentative Target Genes (TTGs) for 
POU5F1
We developed a novel algorithm to identify direct targets
of a TF by first separating genes that responded to TF-
manipulation into groups according to their expression
patterns: direction (up-regulation vs. down-regulation),
magnitude (> 2 fold vs. < 2 fold change) and time (in 12
hr intervals) of response. We then applied the FDR crite-
rion to each group individually (Fig. 1). Genes with tran-
sient response were handled separately from genes with
constitutive response. FDR was estimated in two steps:
first p-values were estimated for each gene on the basis of
the SPF of a binding site in the promoter and cumulative
probability distribution of SPF for binding sites in pro-
moters of control genes. The probability distribution of
SPF in the control set of genes was approximated by a lin-
ear function loge(p|SPF > x) = a + b·x (Additional file 15),
and then the regression was used to calculate p-values.
FDR was then calculated in each group of genes as
described [21]. Numerical examples showing the advan-
tage of this approach are given in the Methods section.
Assuming that we can tolerate up to 20% of false posi-
tives, we set FDR threshold to 0.2 and identified 420 TTGs
of POU5F1 (Fig 2A, Additional file 4). The list of genes
included the majority of known POU5F1 targets (Sox2,
Nanog, Zfp42, Klf4, Esrrb, Utf1, Lefty1, Otx2, Spp1, Upp1,
Fbxo15, Dppa5, Cdyl, Cdx2), which supports the validity of
our analysis. Although one-fifths of these TTGs are in the-
ory false positives due to FDR ≤ 0.2, we believe that this is
the best result we can obtain with the current technology
and uniform data analysis applied to all the genes. Some
genes with strong response to Pou5f1 were not included in
the list of TTGs (e.g., Fgf4), because the FDR values were
slightly above the accepted threshold. We, therefore,
assembled an additional list of 65 genes (Additional file
16) that are likely to be targets of POU5F1 although they
did not pass our statistical criteria. These genes had either
relatively low FDR values or additional evidence of their
regulation by Pou5f1.
A list of target genes identified in this paper matched rea-
sonably with lists of genes identified in earlier studies. Of
420 TTGs identified for Pou5f1, 82 genes overlapped with
a list of genes identified in Matoba et al. [2], and 125
genes overlapped with a list of genes identified in Loh et
al. [1] (Additional file 17). TTGs that were identified in
earlier studies, but not identified in the current study fell
into two categories: (i) TTGs that had weak binding sites;
and (ii) TTGs that did not respond significantly to Pou5f1
manipulation in our experiment, as judged by the distri-
bution of a simple score estimated as a product of SPF and
absolute magnitude of gene expression response to Pou5f1
suppression (Additional file 18). The scores for TTGs
identified in this paper were substantially higher than
those for non-matching genes from the earlier papers,
indicating that the current list of TTGs was high quality.
Furthermore, there was significant overlap between TTGs
identified in the current work and TTGs identified in the
previous meta-analysis of gene expression in ES cells [22]:
out of 83 genes with current gene symbols, 33 genes were
identified as TTGs of POU5F1 in the current work.
Interestingly, we found that Pou5f1 functions mostly as a
positive regulator of target gene expression in ES cells:
among 420 TTGs of POU5F1, the majority (N  = 372;
88.6%) were down-regulated after Pou5f1  suppression
and only 48 TTGs were up-regulated (Fig. 2A). This was a
surprise, because Pou5f1 is thought to suppress the expres-
sion of genes associated with cell differentiation. To
address this issue, we analyzed 420 POU5F1-TTGs and 65
additional TTGs (from Additional file 16) based on Gene
Ontology (GO) terms (Additional file 19) and literature
(PubMed) and found 4 major categories for positive regu-
lation and 1 category for negative regulation (Fig. 4). One
notable category among genes activated by Pou5f1 was the
"suppressors of cell differentiation," which was comprised
of many known and hypothetical transcriptional repres-
sors and signaling repressors (Fig. 4). These include poly-
comb genes such as Suz12 and Phc1, which are known to
repress genes associated with differentiation in ES cells
[23]. Zinc finger TFs are also known as suppressors of gene
expression [24,25]. For example, Klf4 directly suppresses
the expressions of p53 [26], HDC (Hdc) [27], and Sp1
[28], although Klf4  also activates a number of genes,
including Lefty1 [29]. Some of zinc finger TFs activated by
Pou5f1 (e.g., Zfp57, Zfp74, Zfp459) have KRAB domains,BMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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Major functional groups of tentative target genes (TTGs) of POU5F1 Figure 4
Major functional groups of tentative target genes (TTGs) of POU5F1. Genes in blue: genes that passed the criterion 
for TTGs (FDR < 0.2). Genes in red: additional genes that did not pass this criterion but are still likely to be targets.
Polycomb genes:  L3mbtl2, Phc1, Suz12, Rybp
Zinc finger TFs:  Klf2, Klf4, Klf5, Sall4, Trim2, Trim24, Trps1, Zcchc10, Zbtb24, Zfp42, 
Zfp36l1, Zfp57,  Zfp74, Zfp219, Zfp292, Zfp459, Zfp532, Zfp623, Zic3, 
Zmat5, Atfb1, Klf3, Klf8, Klf9,Rest
Chromatin remodeling:  Cdyl, Cdyl2, Chd9, Dnmt3b, Jarid1b, Jarid2, Jmjd2c, Myst4, Sap30, Set, 
Sall4, Tle1, Arid3b, Hells, Jmjd1a, Jmjd1c, Jmjd2a, Smarcad1
TF binding inhibitors:  Id3, Id1, Id4
Signaling inhibitors:  Dusp27, Igfbp2, Sfrp1, Smad7, Dusp12, Inpp5d, Smad6
Proteolysis:  Htra1, Ubqln4, Ubl3, Ubxd4, Usp28
Other repressors:  Foxd3, Nr0b1, Tcf3
Suppressors of cell differentiation
Genes associated with cell proliferation
Genes associated with morphogenesis
Cell cycle:  Cdc42ep3, Cdca5, Fbxo5, Ccne, Cdca7
Cell cycle control:  Dbf4, Mif, Mybl2, Myc, Mycn
DNA metabolism/repair:  Chd9, Edd1, Fancm, Gadd45a, Mkrn1, Parp1, Psme4, Terf1, Usp28, 
Helb, Msh2, Trp53, Trp53bp1, Xrcc5
Growth factors  Lefty1, Trh, Vegfc, Wnt3a
Other:  Dppa3, Esrrb, Gli2, Igfbp2, Kit, Rbpsuh, Sall4, Tcl1, Tdgf1, Tns3, Utf1
Growth factors:  Bmp4, Lefty1, Msc, Nodal, Tdgf1, Tnfsf11, Tnfsf12, Vegfc, Fgf4, Inhbb
Receptors:  Epha1, Epha4, Notch1, Ptch1
Transcription factors:  Etv1, Etv5, Gli2, Nfib, Otx2, Parp1, Pax6, Rbpsuh, Six1, Six4, Tbx3, En2, 
Etv4, Nr5a2
Signal transduction:  Shc1, Sgk1, Socs2, Tns3, Ulk1, Mapk4, Mras, Stmn1
Other:  Cobl, Dab1, Enah, Fgfbp1, Ntn1, Spp1
Major pluripotency-related genes
Dppa3, Dppa5, Esrrb, Foxd3, Klf4, Nanog, Sall4, Sox2, Tcl1, Zfp42, Pou5f1, Tbx3
Differentiation-related genes
Trophectoderm:  Cdx2, Eomes
Cell cycle arrest:  Ches1, Gadd45g, Uhrf2
Apoptosis:  Cfdp1, Cidea, Egln3, Gadd45g
Receptors, growth factors,Arrb1, Epb4.9, Fgf5, Fgfr1, Fgfr2, Gpc4, Tec
signal transduction:
Down-regulated after 
Pou5f1 suppression
Up-regulated after 
Pou5f1 suppression
Gene – target genes with FDR<0.2
Gene – additional genesBMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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which are involved in gene-silencing and heterochroma-
tin formation [30]. Some chromatin remodeling proteins
are also known for suppressing gene expressions [31]. For
example, Dnmt3b  is a de novo DNA methyltransferase
which can contribute to transcription silencing, although
the gene seems dispensable for pluripotency maintenance
[32]. Cdyl is a transcriptional co-repressor which is active
via its CoA-pocket domain [33]. TFs with Jumonji domain
(JmjC) function as histone demethylase and modulate the
chromatin status [34]. Inhibitors of helix-loop-helix TF
binding (Id1, Id3, Id4) are also included in the list. The
"suppression of cell differentiation" category (Fig. 4) also
includes a number of inhibitors of cell signaling, such as
phosphatases (Dusp27,  Dusp12,  Inpp5d), inhibitors of
TGFbeta signaling (Smad7), WNT inhibitor Sfrp1, and IGF
inhibitor Igfbp2. Proteases are also included in the list:
Htra1 inactivates TGFbeta signaling possibly via modifica-
tion of ECM [35]; and ubiquitination-related genes
(Ubqln4, Ubl3, Ubxd4, Usp28) may suppress gene activity
via degradation of transcription-activation complexes.
The  Pou5f1, thus, seems to suppress the expression of
genes associated with cell differentiation by positively reg-
ulating the "suppressors of cell differentiation."
Other groups of TTGs activated directly by POU5F1 are
"major pluripotency-related genes", "genes associated
with cell proliferation", and "genes associated with mor-
phogenesis" (Fig. 4). The first group includes mostly
known targets of POU5F1. Pluripotency-related genes,
Foxd3 and Sall4, which are known for Nanog dependency
[2,36], were also TTGs of POU5F1, because in our experi-
ments they responded to Pou5f1 suppression long before
the change of expression of Nanog. Germ line specific gene
Dppa3 (Stella, Pgc7) was another new TTG of POU5F1.
The group of "genes associated with cell proliferation"
included major regulators of cell cycle (e.g., Mif, Mybl2,
Myc, Mycn), DNA metabolism/repair genes, growth fac-
tors, and others, which are consistent with the earlier
report [31]. Mybl2 (b-Myb, Bmyb) and Myc promote cell
transition from G1 phase to S phase, and therefore con-
tribute to the unique cell cycle structure (long S phase
[37]) in ES cells [38,39]. The regulation of ES cell prolifer-
ation by Tcl1 has also been demonstrated previously [2].
Surprisingly, the group of "genes associated with morpho-
genesis", which included many embryonic growth factors,
receptors, TFs, and signal transduction genes, appeared
positively regulated by Pou5f1. Possibly, Pou5f1 is not the
only transcription regulator of these genes because many
of them remain active in developing embryo even after
full silencing of Pou5f1.
In contrast, a small number of TTGs labeled as "differen-
tiation-related genes" (e.g., Cdx2 and Eomes), was nega-
tively regulated by Pou5f1. It has been shown that
POU5F1 can block the transcriptional auto-activation of
Cdx2 by CDX2 protein [36]. Although these genes have
POU5F1 binding sites identified by ChIP, the functional-
ity of these sites as transcription repressors has not been
confirmed experimentally. If these binding sites are
indeed involved in repression of transcription, then this
mechanism may complement other more generic mecha-
nisms of repression of genes associated with differentia-
tion. For example, Arrb1, Cdx2, Cidea, Eomes, Fgf5, and
Gadd45g have bivalent chromatin domains (carrying both
activating H3K4 tri-methylation and repressing H3K27
tri-methylation) [40], and thus can be repressed via poly-
comb genes.
Thus, the main function of POU5F1 binding to promoters
is activation of target genes, whereas suppression of genes
related to cell differentiation is mostly indirect and medi-
ated by specialized gene silencing mechanisms, many
components of which are activated directly by Pou5f1. The
Pou5f1 may have additional molecular functions besides
direct regulation of transcription (e.g., inactivation of
CDX2 protein via direct binding with POU5F1 protein in
heterochromatin [36]); however these effects are beyond
the scope of this paper. POU5F1 can interact directly with
transcriptional repression complexes in ES cells [41], but
it is not clear to what extent this interaction involves
sequence-specific binding of POU5F1 to DNA.
5. Identification of target genes for SOX2 and NANOG
Target genes for SOX2 and NANOG were identified using
the same strategy as for POU5F1 (Fig. 1). Data sources
used for this analysis are summarized in Additional file 1.
Many TTGs of SOX2 and NANOG overlapped with TTGs
of POU5F1 (Additional file 20). Similarly to Pou5f1, Sox2
and Nanog seem to function as activators of gene expres-
sion rather than repressors: 222 genes (99.1%) were acti-
vated by Sox2 (out of 224 TTGs), and 251 genes (81.0%)
were activated by Nanog (out of 310 TTGs) (Additional
file 21; This table does not include genes that are regulated
indirectly or via protein-protein interaction, e.g. by inacti-
vation of SMAD1 by NANOG [42]).
We also assembled a table of additional TTGs of SOX2
based on human ES cell data, because ChIP data for SOX2
in mouse ES cells are not available and we might have
missed important genes. We used ChIP data for SOX2 in
human ES cells [6] and microarray data in mouse ES cells
after Sox2 suppression (> 2 fold change of gene expres-
sions) [16]. A list of genes is available in Additional file 22
for readers who are interested in these additional genes,
but these genes were not used for further analyses
described below. A gene list may contain a proportion of
false positives larger than 20%, because the target genes of
these TFs do not necessary overlap between human and
mouse ES cells [43,1].BMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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6. Common target genes of POU5F1, SOX2, and NANOG
It has been shown that POU5F1, SOX2, and NANOG pro-
teins co-occupy promoters of a substantial portion of their
target genes in the analysis of ChIP-Chip data of human
ES cells [6]. Consistent with this notion, new lists of TTGs
identified in this paper based on both ChIP data and
expression profiling data showed that out of 700 com-
bined TTGs of POU5F1, SOX2, and NANOG, only 209
Comparison of tentative target genes (TTGs) responding to the suppression of Pou5f1, Sox2, or Nanog Figure 5
Comparison of tentative target genes (TTGs) responding to the suppression of Pou5f1, Sox2, or Nanog. (A) 
Venn diagram of combined TTGs of POU5F1, SOX2, and NANOG. Number of genes that were up-regulated (magenta), 
down-regulated (blue), or had a mixed response (gray) to the suppression of Pou5f1, Sox2, and Nanog. (B) The same Venn dia-
gram as (A) after removing genes with possible indirect effects. (C) Comparison of gene responses to the suppression of 
Pou5f1 and Sox2 (TTGs of POU5F1 that were down-regulated after Pou5f1 suppression): response time ratio = log10(t2/t1) 
where t1 and t2 are response times to Pou5f1 and Sox2 suppression, respectively; difference of response magnitude = m2 - m1, 
where m1 and m2 are response magnitudes (log-ratios) to Pou5f1 and Sox2 suppression, respectively; genes in the blue quadrant 
responded more strongly and faster to Sox2 suppression than to Pou5f1 suppression, and genes in the yellow quadrant 
responded more strongly and faster to Pou5f1 suppression than to Sox2 suppression. (D) Comparison of gene responses to the 
suppression of Pou5f1 and Nanog (TTGs of Pou5f1 that were down-regulated after Pou5f1 suppression); notations are the same 
as in (C).
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genes (29.9%) were affected by one of these TFs; other
TTGs were affected by 2 or 3 TFs (Fig. 5A, Additional file
21). The majority of TTGs were down-regulated after sup-
pression of Pou5f1, Sox2, and/or Nanog (N = 512, 73.1%),
very few were upregulated (N = 74, 10.6%), and some had
a mixed response (N = 114, 16.3%) (Fig. 5A).
One of the concerns was that these common TTGs could
have been erroneously identified, because Pou5f1, Sox2,
and Nanog affect the expression of each other and thereby
indirectly affects downstream gene expressions. To elimi-
nate possible indirect effects, we used our observation that
manipulation of each of these 3 genes changed the expres-
sion of other genes with a substantial delay (> 34 hr),
which makes it possible to separate gene networks
affected by each TF. We plotted another Venn diagram
where effects of Pou5f1, Sox2, and Nanog were counted
only if target genes responded before the response time of
other members within this group of 3 major TFs associ-
ated with ES cell pluripotency (Fig. 5B). Even after
removal of these possible indirect effects, correlation
between effects of Pou5f1,  Sox2, and Nanog  remained
strong.
We also examined a possibility that these co-regulations
occurred by chance. For example, the number of genes
activated by both Pou5f1 and Sox2 (N = 137, Fig. 5B) was
significantly higher than expected from permutation of
1729 genes with strong binding sites (with SPF > 95-per-
centile in control genes); expected overlap was only 43.61
genes (chi-square = 50.95, p < 0.001). Permutation was
limited to genes with strong binding sites to avoid the
possibility that apparent correlation between effects of
Pou5f1, Sox2, and Nanog simply resulted from the use of
the same ChIP dataset for selecting TTGs for these TFs. The
number of genes activated by both Pou5f1 and Nanog (N
= 63) was also significantly higher than expected from
permutation (31.96 genes; chi-square = 10.43, p = 0.001).
In contrast, co-activation of genes by Sox2  and  Nanog
appeared non-significant: only 31 genes were activated by
both TFs versus expected 17.99 genes (chi-square = 3.51,
p = 0.06). Effect of Pou5f1 and Sox2 was similar not only
in activation but also in suppression of target genes. The
number of genes suppressed by both Pou5f1 and Sox2 (N
= 14) was statistically higher than expected from permuta-
tion (expected N = 1.23, chi-square = 10.75, p = 0.001).
These genes included cell-cycle suppressor Gadd45g, FGF-
signaling genes (Fgf5, Fgfr2), and TFs Eomes and Dmrt1.
Expression of TTGs of POU5F1, SOX2, and NANOG may
be regulated by other factors as well. To distinguish genes
that are predominantly regulated by Pou5f1 and Nanog,
we analyzed the expression of TTGs in lineage committed
cell types reported previously: mouse trophoblast stem
cells (TS), neural stem cells (NS), and embryonic fibrob-
lasts (MEF) [44,45,19]. Pou5f1  and  Nanog  are not
expressed in these cell types. However, Sox2 is expressed in
NS and TS (lower expression levels than in ES cells), but is
not expressed in MEF. We expected that genes that are pre-
dominantly regulated by Pou5f1 and Nanog will change
their expressions in these cell types in the same direction
as in the ES with suppressed expression of Pou5f1  or
Nanog. Out of 700 TTGs, 383 were consistently down-reg-
ulated and 94 were consistently up-regulated in lineage-
committed cells (Additional file 21). In the former group
92.7% genes were down-regulated after suppression of
either Pou5f1 (N = 324) or Nanog (N = 159), and in the
latter group only 42.6% genes were up-regulated after sup-
pression of Pou5f1 (N = 33) or Nanog (N = 18). In total,
we found 395 TTGs that were expected to be predomi-
nantly regulated by Pou5f1 and Nanog, and the majority of
them (N = 355) were activated by these TFs (Additional
file 21).
7. Differential effects of Pou5f1, Sox2 and Nanog on their 
TTGs
Although Pou5f1, Sox2, and Nanog cooperate strongly in
their effects on target genes, their roles may not be equal.
For example, Sox2 is dispensable in activation of several
known gene expression enhancers with OCT-SOX com-
posite binding site [16]. Thus, we wanted to check if the
same was true for other genes activated by Pou5f1. Among
378 TTGs of POU5F1 that were down-regulated after
Pou5f1 suppression, 131 were not affected by Sox2 sup-
pression, and 148 responded more weakly and with delay
compared to their response to Pou5f1 suppression (Fig.
5C, upper right quadrant). Some genes from the latter set
may be affected by Sox2 only indirectly via Pou5f1 sup-
pression; however testing this hypothesis would require
further study. Only 12 genes responded to Sox2 suppres-
sion more strongly and faster compared with their
response to Pou5f1 suppression (Fig. 5C, lower left quad-
rant).
Similarly, out of 378 TTGs of POU5F1 that were down-
regulated after Pou5f1 suppression, 237 were not affected
by Nanog, and 33 responded to Nanog suppression weaker
and with delay compared to their response to Pou5f1 sup-
pression (Fig. 5D, upper right quadrant). Small number of
genes responding to Nanog manipulation can be partially
explained by the fact that suppression of Nanog did not
change the expression of Pou5f1 in both knockdown and
overexpression experiments, and therefore, there were no
indirect effects mediated by Pou5f1. Only 5 genes
responded to Nanog suppression more strongly and faster
compared to their response to Pou5f1 suppression (Fig.
5D, lower left quadrant). Genes that responded more
strongly (but not necessary faster) to Nanog suppression
compared to Pou5f1 suppression (N = 13) were enriched
in genes associated with growth factor activity (Bmp4,BMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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Spred2, Spry4, Igfbp2). Thus, although Pou5f1, Sox2, and
Nanog cooperate in activation of TTGs, Pou5f1 plays the
major role in this cooperation, whereas Sox2 and Nanog
generally have a weaker effect. However, there were excep-
tions from this general rule because some genes were
affected more strongly by Sox2 or Nanog than by Pou5f1.
Examples of differential effects of Pou5f1, Sox2, or Nanog
on their TTGs are given in Fig. 6. Many suppressors of cell
differentiation (e.g., Dnmt3b,  Foxd3,  Id4,  Jmjd2c, and
Suz12) were activated by Pou5f1  and  Sox2  but not by
Nanog, whereas several genes associated with ES cell
pluripotency (Esrrb, Sfrp1, Tdgf1, Zfp42) were activated by
Pou5f1 and Nanog but not by Sox2. Some pluripotency-
related genes (e.g., Dppa5 (Esg1) and Utf1) were activated
solely by Pou5f1. Germline markers Dppa3 (Stella) and
Dazl were activated by Pou5f1 and Sox2 but either sup-
pressed (Dppa3) or not affected (Dazl) by Nanog. Trophec-
toderm marker Cdx2  was suppressed by Pou5f1  and
Nanog, whereas another trophectoderm marker Eomes was
suppressed by Pou5f1 and Sox2 but not by Nanog. Genes
associated with morphogenesis, Lefty1 and Nodal, were
suppressed by Sox2 and Nanog but activated by Pou5f1.
Differential effect of Pou5f1, Sox2, and Nanog on target
genes may be important for embryo patterning and regu-
lation of metabolism.
Some differential effects were observed on quantitative
level only. For example, TTGs of Sox2 that were down-reg-
ulated more strongly (but not necessary faster) after Sox2
suppression compared to Pou5f1 suppression (N = 100,
Additional file 21) were enriched in genes associated with
neural differentiation (Dab1, Fut9,  Notch1,  Nrp2,  Pax6,
Gbx2, Nef, Zic2, Zic5), and first 5 of these genes were over-
expressed in NS compared to ES, according to published
data [45,44]. Interestingly, additional TTGs of SOX2 that
had no POU5F1 or NANOG binding sites, were also
enriched in genes that were over-expressed in NS (e.g.,
Cdh2, Dpysl3, Fez1, Lrrn1, Pdzrn4, Sema6a, Timp4, Vim,
Zic1) (Additional file 22). These observations are consist-
ent with a known role of Sox2 in neural differentiation
[46,47].
Examples of tentative target genes responding differentially to the suppression of Pou5f1, Sox2, and Nanog Figure 6
Examples of tentative target genes responding differentially to the suppression of Pou5f1, Sox2, and Nanog.
Ccnb1, Erf, Esrrb, Fgf4, Jak3, 
Mras, Mtss1, Mybl2, Ptch1, 
Rest, Sfrp1, Sgk, Spred2, 
Tdgf1, Trps1, Tcfcp2l1, Zfp42
Dazl, Dnmt3b, Etv1, Foxd3, 
Gbx2, Id4, Jmjd2c, Klf2, Mkrn1, 
Morc1, Mup4, Mycn, Notch1, 
Otx2, Pou5f1, Sap30, Set, 
Suz12, Terf1, Tle1, Upp1, Zic3
Dppa5, Epha1, Epha4, Fbxo15, 
Ncor1, Socs3, Tcf3, Tcfe3, Utf1
Arid5b, Oas1f, Ptger2, Zic2
Brd2, Ccdc5, Fbxo2, Fgf17, 
Foxp1, Fzd5, Itpr3, Mid1, Rara, 
Rarg, Sall1
Myb, Yes1, Zic5
Ccng2, Egln3, 
Scd1
Dppa3, Gja1, Trh
Lefty1, Nodal
Fgfbp1, Id3, Klf5, 
Myc, Sall4, 
Cdc42ep3, Six1, 
Six4, Smad7
Gli2, Inhbb, Lrrc2
Arrb1, Cidea, Dmrt1, 
Eomes, Qk, Smarca2, 
Tec
Cdx2, Fat1
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Ets2, Foxh1, Prickle1
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Conclusion
We have developed a novel algorithm to evaluate the sta-
tistical significance of direct downstream target genes for
a TF. The method uses two data inputs: genome-wide
time-course expression profiling data after the manipula-
tion of TF expression level; and genome-wide ChIP data.
We have applied this method to key pluripotency genes –
Pou5f1, Sox2, and Nanog, and identified their TTGs in ES
cells. Because the majority of TTGs were activated and
only a few of them were suppressed, we conclude for the
first time that the main function of Pou5f1,  Sox2, and
Nanog when they are bound to promoters is activation of
gene expression rather than suppression. Thus, the role of
these TFs in suppression of genes associated with differen-
tiation is mostly indirect and is mediated via specialized
gene silencing mechanisms. This idea is supported by our
observation that transcription of many components of
these silencing pathways is directly activated by Pou5f1,
Sox2, and Nanog. These 3 genes may have additional
molecular functions that are not related to binding to the
promoters of target genes, but these functions cannot be
inferred from ChIP data and therefore require different
methods of analysis.
Methods
Microarray experiments
For microarray experiments we used ZHBTc4 ES cells with
a Tet-inducible Pou5f1 transgene [4]. Cells were cultured
for 2 passages on gelatin-coated plates in order to remove
feeder cells and then transferred to gelatin-coated 6-well
plates at the density of 1–2 × 105 cells/well and cultured
in complete ES medium: DMEM, 15% FBS; LIF (ESGRO,
Chemicon, USA) 1000 U/ml; 1 mM sodium pyruvate; 0.1
mM NEAA, 2 mM glutamate, 0.1 mM beta-mercaptoetha-
nol, and penicillin/streptomycin (50 U/50 μg per ml).
Tetracycline was added at 24 hr after cell plating, and then
cells were harvested at 0 hr (before adding tetracycline), 3
hr, 6 hr, 12 hr, and 24 hr (2 replications each). RNA sam-
ples for later time points (24, 48, 72, 96, and 120 hr) were
obtained from our earlier experiment with 3 replications
[2]. Two Nanog over-expressing clones were tested: inte-
grated and episomal transgene. To generate an integrated
transgene, Nanog cDNA was amplified by PCR and cloned
into pEF6/pIRESneo3 vector (Invitrogen). Nanog-pEF6/
pIRESneo3 construct was transfected into MC1 cell line
(129S6/SvEvTac strain; purchased from the Transgenic
Core Laboratory of the Johns Hopkins University School
of Medicine). After 10 days of selection in 300 ug/ml
G418 (Invitrogen), resistant colonies were picked and
expanded. To generate an episomal transgene, plasmid
construct was made by cloning Nanog cDNA into pPyCA-
GIP episomal expression vector [48]. Nanog-pPyCAGIP
episomal expression construct was transfected into
MG1.19 cell line, expressing polyoma T large antigen [49].
After 7 days of puromycin selection, 2 μg/ml, resistant col-
onies were picked, expanded and Nanog expression level
was confirmed by real time PCR: it was 2.14 ± 0.14 fold
for the integrated clone and 19.6 ± 1.1 fold for the episo-
mal clone. Both Nanog transgenic and parental cell lines
were cultured for 2 passages on gelatin-coated plates and
then transferred to gelatin-coated 6-well plates at the den-
sity of 1–2 × 105 cells/well and cultured for 3 days in 3 dif-
ferent conditions: (1) complete ES medium (see above);
(2) complete medium without LIF, and (3) complete
medium with 1 μM RA. Cells were cultured at 37°C and
5% CO2 condition and the culture medium was changed
daily.
Total RNAs were extracted using Trizol™ (1 ml/well; Invit-
rogen, USA) and Phase lock gel™ columns (Eppendorf/
Brinkman) according to the manufacturer's protocol.
Total RNAs were precipitated with isopropanol, washed
with 70% ethanol, and dissolved in DEPC-treated H2O.
2.5 μg of total RNA samples were labeled with Cy3-CTP
using a Low RNA Input Fluorescent Linear Amplification
Kit (Agilent, USA). A reference target (Cy5-CTP-labeled)
was prepared from the Universal Mouse Reference (UMR)
RNA (Stratagene, USA). Labeled targets were purified
using an RNeasy Mini Kit (Qiagen, USA) according to the
Agilent's protocol, quantified by a NanoDrop scanning
spectrophotometer (NanoDrop Technologies, USA), and
hybridized to the NIA Mouse 44 K Microarray v2.1 (whole
genome 60-mer oligo; manufactured by Agilent Technol-
ogies, #012799) and NIA Mouse 44 K Microarray v2.2
(whole genome 60-mer oligo; manufactured by Agilent
Technologies, #014117) [19] according to the Agilent
protocol (G4140-90030; Agilent 60-mer oligo microarray
processing protocol – SSC Wash, v1.0). RNA samples
from experiment of [2] were hybridized to NIA Mouse 22
K Microarray Dev2 (Agilent Technologies, design
#012165) [19]. All hybridizations were carried out in the
two color protocol by combining one Cy3-CTP-labeled
experimental target and Cy5-CTP-labeled reference target.
Microarrays were scanned on an Agilent DNA Microarray
Scanner, using standard settings, including automatic
PMT adjustment.
Statistical analysis of microarrays
The data discussed in this publication have been depos-
ited in NCBI Gene Expression Omnibus and are accessible
through GEO Series accession number (GSE8617). All the
microarray data are available at the public GEO website
[50,51]. The data and analysis software are also available
at the NIA Array Analysis website [52,53]. Because some
arrays showed slight reduction of Cy5 signal (UMR) due
to ozone bleaching we compensated for this effect as fol-
lows. First we selected 100 genes with the highest vari-
ances of Cy5 signal and with average log10-signal > 2.5,
and estimated the average Cy5 signal for these genes in
each array which roughly represented the degree ofBMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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bleaching effect. Then we used a linear regression to fit
Cy5 log signal for each gene as a function of the bleaching
effect (average log Cy5 signal of 100 genes described
above), and the Cy3 signal in the same array. Then the
effect of bleaching was subtracted. If after this correction,
log Cy5 signal in array differed by > 3·SD from the mean
log Cy5 signal it was replaced by the mean. Data on earlier
time points (3–24 hr) was combined with data on later
time points (24–120 hr)[2] that was adjusted as follows:
x't = xt - x24 + y24, where xt and x't are log gene expression for
time point > 24 hr before and after adjustment, respec-
tively, x24 is log gene expression in the experiment of [2],
and y24 is log gene expression in the new experiment. For
the majority of genes we used the same oligo sequence in
both data sets that were combined. However, for some
genes that had no common oligo we combined data from
different oligos. Data on genes that had no oligo (or no
sensitive oligo) in NIA Mouse 22 K Microarray Dev2 (N =
109) were taken from NIA Mouse 22 K Microarray Dev1
presented in [2]. Information on Cdx2 is based on PCR
data (Additional file 23) because our microarray probe for
this gene was not responsive. Source of data for each gene
is listed in Additional file 2.
Statistical analysis was done using the NIA Array Analysis
software [52]. To reduce the number of false positives we
used the maximum of the actual error variances for a gene
and the average error variance estimated from 500 genes
with similar signal intensity. Difference in expression was
considered significant on the basis of false discovery rate
FDR ≤ 0.05, which accounts for the effect of multiple
hypotheses testing. Time of gene response to Pou5f1 sup-
pression was estimated as the time when interpolated
gene expression reached the level of 1.5 fold difference
compared to the 0 hr initial time point, and the magni-
tude of response was estimated as the maximum log-ratio
of gene expression (either positive or negative) compared
to 0 hr (see Fig. 2C). Expression change was considered
transient if after reaching its peak (positive or negative), it
declined to < 1.5 fold change or became inverted. Gene
ontology (GO) analysis was done using the NIA Mouse
Gene Index software, which evaluates statistical signifi-
cance using the hypergeometric probability distribution
with parameters: FDR = 0.05, over-representation ratio >
1.5 fold [54-56].
Identification of tentative target genes (TTGs)
To identify TTGs we optimized parameters of the score of
potential function (SPF) (equation 1) to distinguish best
between training and control sets of genes. Training sets
were genes that were down-regulated or up-regulated by at
least 2 fold and responded non-transiently to Pou5f1 sup-
pression within the time window from 6 to 48 hr (Addi-
tional file 11). Genes that responded too early (< 6 hr)
were not included in the training set because there may
have been not enough time for the concentration of
Pou5f1 protein to drop substantially (see Additional file
3), and therefore the response may have been caused by
other factors. Similarly genes that responded late (> 48)
were not included in the training set because many of
them may be affected indirectly. The set of control genes
was defined as a set of genes with high-quality or
medium-quality promoters [17]which did not respond to
suppression of Pou5f1 in ZHBTc4 ES cells (FDR > 0.05)
and were not differentially expressed between ES and TS
cells (FDR > 0.05) [19]. Pou5f1 gene is expressed in ES
cells but not in TS cells [57], therefore we expected that the
expression of Pou5f1 target genes was different in these
types of cells. No change in gene expression measured by
microarray may have resulted from non-responding oli-
gos. Thus, we further narrowed down the list of control
genes to those genes that showed differential expression
(FDR ≤ 0.05 and > 1.5 fold change) between ovary and
testis measured with the same array platform [11] to con-
firm the functionality of oligos. SPF was estimated based
on the strength of Pou5f1 and Nanog binding [1], distance
from TSS, and CpG-richness of the DNA region. TSS coor-
dinates in mouse genome assembly mm6 were taken from
[17], and coordinates of ChIP-PET regions were converted
to genome version mm6 using UCSC batch conversion
tool [58]. Association between binding sites and TSSs was
established using the following rules: (1) if distance to TSS
of gene A was > 3 fold greater than distance to TSS of gene
B, then binding site was associated only with gene B, oth-
erwise it was associated with both A and B; (2) if genes A
and B have a common bidirectional promoter with dis-
tance between TSSs < 1 K then binding sites were associ-
ated with both genes; (3) non-RefSeq genes were ignored
unless they responded to Pou5f1 manipulation (this rule
was needed to avoid association with antisense regulatory
transcripts); and (4) distance between binding site and
TSS was limited to 200 K. CpG-rich regions were those
that contained minimum of 8 CpG pairs within 250 bp
[17]. Initially we included the effect of repeats and bind-
ing motifs in SPF, but then we removed them because they
were not significant. Optimization was done separately
for 2 training sets of genes that were down-regulated and
up-regulated after suppression of Pou5f1. To optimize the
parameters of the SPF we used the simplex method imple-
mented in a Perl script based on the published algorithm
[59]. At each step of optimization, scores were re-calcu-
lated according to modified parameters, binding sites
with the highest score were selected for each gene, and
then these scores were compared between training genes
and control genes using t-statistics. To avoid a circular ref-
erence by estimating SPF for genes in the training and con-
trol set with parameters optimized for the same genes, we
used the bootstrap resampling method [20]. Both training
and control sets of genes were randomly split into 10 por-
tions, and optimization was repeated 10 times with oneBMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
Page 15 of 19
(page number not for citation purposes)
portion of training and control genes excluded. Then,
parameters (a, b, c, and d) in equation (1) were averaged;
however when estimating SPFs for genes that belong to
the i-th portion of training or control genes we averaged
only those values that were optimized without the i-th
portion of genes. The probability distribution of binding
scores among control genes was used for estimating the p-
value, and then the FDR was estimated using the method
of [21] in each group of genes that differ by time, direc-
tion, and magnitude of response to manipulation of the
TF. TTGs were selected using FDR = 0.2 as a threshold.
Because each group has a large number of genes (median
= 160), FDR in each group can be interpreted as the pro-
portion of false positives among genes that are assumed
significant in this group. Thus, the total proportion of
false positives among pooled significant genes from all
groups should also be close to the FDR threshold. This
method is based on the assumption that SPF represents
correctly the role of binding sites in transcription regula-
tion. This assumption is not always true because SPF esti-
mation is based on the limited information that is
available; thus binding sites with the highest SPF for each
gene are not necessary the ones that act as main regulatory
switches. The quality of analysis can be improved as addi-
tional information becomes available (e.g., luciferase
assay and location of insulators).
Numerical examples
The purpose of these examples is to show the advantage of
the proposed method for detecting direct target genes
compared to the traditional approach when all genes that
responded to manipulation of a TF and have a binding
site in their promoter are considered direct targets. Our
method for identification of direct targets of a TF is based
on splitting the genes that responded to TF manipulation
into groups according to the direction, magnitude and
time of their response, and then applying the FDR crite-
rion within each group (Fig. 1). In the first example we
assume that all true binding sites are known, and there-
fore there is no need for using SPF. There are 5000 genes
that responded to manipulation of TF which are split into
10 groups according to the direction, magnitude and time
of response. For simplicity we assume that all groups have
equal number of genes, and only 2 of these groups con-
tained true direct target genes. The proportion of target
genes in these 2 groups was 40% and in other groups it
was 0%. Binding sites are present in promoters of all true
target genes and in 20% of other genes (non-functional
binding). If we consider all responding genes with bind-
ing sites as TTGs, then we would find 1320 of these genes
which include 69.7% of false positives. Using our
approach, we select genes with binding sites only in 2
groups of responding genes that had a significantly higher
proportion of genes with binding sites (52% versus 20%
in control). As a result, 520 TTGs are detected and they
contain only 23% of false positives. Here our method
yielded a 3-fold reduction in the proportion of false posi-
tives. The second example, which is more realistic,
assumes that there is no clear-cut distinction between true
and false binding sites. Instead, binding sites are charac-
terized quantitatively by SPF. We modify the previous
example by assuming that true target genes have a normal
distribution of SPF with M = 7 and SD = 2, whereas other
genes have a normal distribution of SPF with M = 3 and
SD = 2. Assuming that we can tolerate 25% of false posi-
tives, we set FDR threshold to 0.25. Using the method of
[21] and p-values from the probability distribution of SPF
in control genes, we estimated that this FDR = 0.25 corre-
sponds to the threshold of SPF = 5.75 in groups that con-
tain true target genes, and is unattainable in groups
without true target genes. As a result, 347 TTGs are identi-
fied, and 52 of them are false positives (15%). Proposed
method reduced the proportion of false positives by > 3
fold and increased the number of identified true target
genes by 47%. The actual proportion of false positives
appeared slightly lower than the target FDR rate because
we assumed that the distribution of SPF among true tar-
gets is unknown.
Real-time quantitative RT-PCR
Primers for quantitative reverse transcriptase PCR (qRT-
PCR) were designed and tested for SYBR Green chemistry
using an established in-house protocol [57]. Primers for
Cdx2 were ACGTACATGGTGGCGAGGGA (forward), and
GGGAGGCAGAAGCTCTGCAA (reverse), and primers for
Nanog  were CTGGGAACGCCTCATCAA (forward), and
CATCTTCTGCTTCCTGGCAA (reverse). Primers for
Pou5f1  (transgene-specific) were ACGAGTGGAAAG-
CAACTCA and AGATGGTGGTCTGGCTGAAC. Total RNA
was used to prepare cDNA as described previously [57].
Reactions were run on ABI 7900 HT Sequence Detection
Systems using the default cycling program, and data were
processed using SDS 2.2 software (Applied Biosystems).
Western blot analysis
Protein amounts of each sample were quantified using the
RC DC protein assay kit (Bio-Rad, 500–0119). For west-
ern blotting, the samples were boiled for 5 min and
loaded onto a 8–16% SDS-polyacrylamide gel. The elec-
trophoretically separated proteins were transferred to
immobilon-P membrane (Millipore). The membrane fil-
ters were blocked with PBST (1× PBS, 0.05% Tween 20)
containing 5% nonfat milk powder (PBST-Milk) at room
temperature for 1 h and then washed three times each
with PBS-T for 5 min. The primary antibodies against
POU5F1 (sc-5279, Santa Cruz Biotechnology, Inc.) and
UBTF (UBF) (sc-13125, Santa Cruz Biotechnology, Inc.)
diluted at 1:10000 in PBST-Milk were applied at room
temperature for 1 h. After three washes with the PBS-T, the
secondary HRP-conjugated IgG (1:3000 dilution) inBMC Genomics 2008, 9:269 http://www.biomedcentral.com/1471-2164/9/269
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PBST-Milk was applied at room temperature with agita-
tion for 30 minutes. The filters were washed again, treated
with the ECL Western Blotting Detection Reagents (GE
Healthcare, USA), and exposed to a film for visualization.
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